Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MGMT | P16455 | 9/20 | 0.66 |
| ▸ | CDK1 | P06493 | 2/20 | 0.66 |
| ▸ | CCNB1 | P14635 | 2/20 | 0.66 |
| ▸ | CCNA2 | P20248 | 2/20 | 0.66 |
| ▸ | CDK2 | P24941 | 2/20 | 0.66 |
| ▸ | CCNA1 | P78396 | 2/20 | 0.66 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.55 |
| ▸ | PIN1 | Q13526 | 2/20 | 0.55 |
| ▸ | MPO | P05164 | 1/20 | 0.55 |
| ▸ | TPO | P07202 | 1/20 | 0.55 |
| ▸ | EPX | P11678 | 1/20 | 0.55 |
| ▸ | LMNA | P02545 | 1/20 | 0.55 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.55 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.55 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.55 |
| ▸ | TSHR | P16473 | 1/20 | 0.55 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.55 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.55 |
| ▸ | BLM | P54132 | 1/20 | 0.55 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3338311 | 0.85 | MGMT (0.68) | MGMTCDK1CCNB1CCNA2CDK2 | |
| SCHEMBL16852229 | 0.82 | MGMT (0.64) | MGMTCDK1CCNB1CCNA2CDK2 | |
| SCHEMBL2054835 | 0.80 | MGMT (1.00) | MGMTCDK1CCNB1CCNA2CDK2 | |
| SCHEMBL669089 | 0.79 | MGMT (0.52) | MGMTCDK1CCNB1CCNA2CDK2 | |
| SCHEMBL6362726 | 0.78 | MGMT (0.63) | MGMTCDK1CCNB1CCNA2CDK2 | |
| SCHEMBL6362719 | 0.78 | MGMT (0.63) | MGMTCDK1CCNB1CCNA2CDK2 | |
| SCHEMBL7144843 | 0.78 | ADORA2A (0.49) | MGMTCDK1CCNB1CCNA2CDK2 | |
| SCHEMBL21226762 | 0.77 | MGMT (0.51) | MGMTCDK1CCNB1CCNA2CDK2 | |
| SCHEMBL25345378 | 0.77 | MGMT (0.50) | MGMTCDK1CCNB1CCNA2CDK2 | |
| SCHEMBL557629 | 0.77 | MGMT (0.50) | MGMTCDK1CCNB1CCNA2CDK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-100563710-C | The anticancer medicine slow-release preparation containing that contains pyrimidine analogue | JINAN SHUAIHUA MEDICINE SCI TE (CN) | 2009-12-02 | — | — | CN | disclosed |
| CN-100500215-C | Sustained-release injection containing methotrexate and synergist thereof | JINAN SHUAIHUA MEDICINE SCI TE (CN) | 2009-06-17 | — | — | CN | disclosed |
| CN-101380306-A | Compound platinum medicine sustained-release agent | JINAN SHUAIHUA PHARMACEUTICAL (CN) | 2009-03-11 | — | — | CN | disclosed |
| CN-101380297-A | Compound platinum medicine sustained-release agent | JINAN SHUAIHUA PHARMACEUTICAL (CN) | 2009-03-11 | — | — | CN | disclosed |
| CN-101292956-A | Sustained-release injection containing methotrexate and its synergistic agent | JINAN SHUAIHUA PHARMACEUTICAL (CN) | 2008-10-29 | — | — | CN | disclosed |
| CN-101292955-A | Sustained-release injection containing fluorouracil synergistic agent and preparation method thereof | JINAN SHUAIHUA PHARMACEUTICAL (CN) | 2008-10-29 | — | — | CN | disclosed |
| CN-101244033-A | Sustained-release agent containing taxone and its synergistic agent | JINAN KANGQUAN PHARMACEUTICAL (CN) | 2008-08-20 | — | — | CN | disclosed |
| CN-101244034-A | Sustained-release agent containing taxone and its synergistic agent | JINAN KANGQUAN PHARMACEUTICAL (CN) | 2008-08-20 | — | — | CN | disclosed |
| CN-100386115-C | Anti-cancer medicine composition | QINGZHONG KONG (CN) | 2008-05-07 | — | — | CN | disclosed |
| CN-1923171-A | Compound recipe anti-cancer drugs slow release agent comprising anticancer antibiotics and booster thereof | JINAN KANGQUAN PHARMACEUTICAL (CN) | 2007-03-07 | — | — | CN | disclosed |
| US-6333331-B1 | USEFUL IN INACTIVATING THE HUMAN DNA REPAIR PROTEIN O.SUP.6 -ALKYLGUANINE-DNA ALKYLTRANSFERASE; ANTICANCER AGENTS | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES | 2001-12-25 | — | — | US | disclosed |
| US-6303604-B1 | USED AS ANTINEOPLASTIC ALKYLATING AGENT WHICH CAUSES CYTOTOXIC LESIONS AT THE O.SUP.6-POSITION OF QUANINE | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES | 2001-10-16 | — | — | US | disclosed |
| EP-1142893-A1 | Substituted O6-benzylguanines and 6(4)-benzyloxypyrimidines | THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, Department of Health and Human Services (US) | 2001-10-10 | — | — | EP | disclosed |
| US-6172070-B1 | IN POLYOXYETHYLENE GLYCOL CARRIER | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES | 2001-01-09 | — | — | US | disclosed |
| US-5958932-A | ANTITUMOR AGENT | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1999-09-28 | — | — | US | disclosed |
| US-5916894-A | Substituted 06-benzylguanines and 6(4)-benzyloxypyrimidines | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1999-06-29 | — | — | US | disclosed |
| US-5753668-A | Substituted benzyloxypyrimidines and their inactivation of O6 -alkylguanine-DNA alkyltransferase | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1998-05-19 | — | — | US | disclosed |
| EP-0775142-A1 | SUBSTITUTED O6 -BENZYLGUANINES AND 6(4)-BENZYLOXYPYRIMIDINES | THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, Department of Health and Human Services (US) | 1997-05-28 | — | — | EP | disclosed |
| US-5525606-A | CHEMOTHERAPEUTIC ANTITUMOR AGENT | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1996-06-11 | — | — | US | disclosed |
| WO-1996004281-A1 | SUBSTITUTED O6-BENZYLGUANINES AND 6(4)-BENZYLOXYPYRIMIDINES | THE UNITED STATES OF AMERICA, REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1996-02-15 | — | — | WO | disclosed |